Clinical trial
The Safety and Efficacy of Photodynamic Therapy for Femoral Artery Stenosis
NCT00187811 · University College London Hospitals, Other · Unknown status
Key facts
| NCT number | NCT00187811 |
|---|---|
| Title | The Safety and Efficacy of Photodynamic Therapy for Femoral Artery Stenosis |
| Official title | Randomised Controlled Trial of Adjuvant Photodynamic Therapy to Reduce Restenosis After Percutaneous Transluminal Angioplasty to the Superficial Femoral Angioplasty |
| Lead sponsor | University College London Hospitals, Other |
| Collaborators | UCL/UCLH Clinical Research and Development Fund |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerotic Narrowing of the Superficial Femoral Artery, Atherosclerotic Occlusion of the Superficial Femoral Artery |
| Intervention type | Procedure |
| Interventions | Delta amino leavulinic acid photodynamic therapy |
| Enrollment | 120 |
| Start date | Feb 1, 2001 |
| Completion | Jun 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 29, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: